Jefferies Raises Energy Transfer (ET) Price Target, Calls Gas Project Updates ‘Rather Exceptional’
On February 18, Jefferies analyst Julien Dumoulin-Smith raised his price objective on Energy Transfer LP (NYSE:ET) to $20 from $17.
Insider Monkey Blog
Stephens Sees Stronger Outlook for Griffon (GFF), Raises Target after Q1 Beat
On February 9, Stephens analyst Trey Grooms raised his price recommendation on Griffon Corporation (NYSE:GFF) to $115 from $92.
Barclays Cuts S&P Global (SPGI) Price Target but Maintains Overweight Rating
On February 23, Barclays analyst Manav Patnaik lowered his price recommendation on S&P Global Inc. (NYSE:SPGI) to $565 from $620.
Morgan Stanley Boosts Avient (AVNT) Price Forecast Following Q4 EPS Review
On February 17, Morgan Stanley raised its price recommendation on Avient Corporation (NYSE:AVNT) to $52 from $41. The firm maintained an Equal Weight rating on the shares.
Roth Capital Raises Patrick Industries (PATK) Price Target After ‘Outsized’ Q4 Beat
On February 9, Roth Capital analyst Scott Stember raised his price recommendation on Patrick Industries, Inc.
Morgan Stanley Raises Spire Global (SPIR) Target as Utility Outlook Evolves
On February 20, Morgan Stanley raised its price recommendation on Spire Global, Inc. (NYSE:SPIR) to $100 from $93. It reiterated an Overweight rating on the shares.
UBS Maintains Buy on Wynn Resorts (WYNN), Notes Move toward Stronger Free Cash Flow
On February 23, UBS lowered its price recommendation on Wynn Resorts, Limited (NASDAQ:WYNN) to $146 from $148. The firm reiterated a Buy rating on the shares.
BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure
On February 13, BofA lowered its price recommendation on West Pharmaceutical Services, Inc. (NYSE:WST) to $300 from $370. It reiterated a Buy rating on the stock.
Truist Raises Cigna (CI) Price Target to $350, Sees Clearer Growth Outlook after Q4
On February 17, Truist raised its price recommendation on The Cigna Group (NYSE:CI) to $350 from $320. The firm reiterated a Buy rating on the stock.
10 Best Stocks for Beginners with Little Money in 2026
On February 19, Joseph Stiglitz, the Nobel Prize-winning economist and ‘The Road to Freedom’ author, joined CNBC's 'Squawk Box' to discuss the state of the economy and argued...
13 Best Strong Buy Dividend Stocks to Invest In
In uncertain times, large companies that pay strong dividends tend to attract more attention, as these businesses generate profits supported by steady cash flows, which help sustain...
Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
TheFly reported on February 18 that Evercore ISI reinstated coverage of BCRX with an Outperform rating and a $17 price target.
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
TheFly reported on February 19 that Bank of America raised its price target for Bausch + Lomb (BLCO) to $15 from $13 and kept an Underperform rating.
Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7%
TheFly reported on February 12 that OGN announced its fourth-quarter and full-year 2025 financial results.
Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
TheFly reported on February 3 that Lake Street Capital Markets reduced its price target on AQST to $6 from $8 and maintained a Buy rating. This update followed the company...
Sanofi’s (SNY) R&D Track Record Remains Investor Concern, Says BofA
TheFly reported that on February 20, SNY’s price target was lowered at Citi by EUR 5.
Truist Lowers Neurocrine Biosciences, Inc.’s (NBIX) PT Following 2026 Outlook Update
TheFly reported on February 17 that Truist reduced its price target on NBIX to $140 from $169 and maintained a Buy rating on the stock. The increase came after management...
Hims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition
HIMS declared on February 19, 2026, that it has finalized a deal to purchase Eucalyptus for a maximum of $1.15 billion, subject to usual adjustments.
Alphabet Inc. (GOOGL): Loblaw Companies Limited Enters into New Collaboration
Alphabet Inc. (NASDAQ:GOOGL) is one of the Unstoppable AI Stocks to Invest In Now.
Innodata Inc. (INOD) Expands Role as AI Data Engineering Partner
Innodata Inc. (NASDAQ:INOD) is one of the AI stocks that will go to the moon. On January 29, Innodata Inc.
Recursion Pharmaceuticals, Inc. (RXRX) Advances AI Drug Discovery Amid Market Shifts
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion Pharmaceuticals, Inc.
Citi Lowers PT on Broadcom Inc. (AVGO) Stock
Broadcom Inc. (NASDAQ:AVGO) is one of the Unstoppable AI Stocks to Invest In Now.
Goldman Sachs Raises PT on Arista Networks, Inc. (ANET) Stock
Arista Networks, Inc. (NYSE:ANET) is one of the Unstoppable AI Stocks to Invest In Now.
Cloudflare, Inc. (NET) Enters into Strategic Partnership with Mastercard Incorporated
Cloudflare, Inc. (NYSE:NET) is one of the Unstoppable AI Stocks to Invest In Now.
B. Riley Raises PT on Onto Innovation Inc. (ONTO) Stock
Onto Innovation Inc. (NYSE:ONTO) is one of the Unstoppable AI Stocks to Invest In Now. On February 20, B.
Goldman Sachs Initiates Coverage of Credo Technology Group Holding Ltd (CRDO) Stock
Credo Technology Group Holding Ltd (NASDAQ:CRDO) is one of the Unstoppable AI Stocks to Invest In Now.
Leidos Holdings, Inc. (LDOS) Releases Financial Results for Q4 2025 and FY 2025
Leidos Holdings, Inc. (NYSE:LDOS) is one of the Unstoppable AI Stocks to Invest In Now.
InterDigital, Inc. (IDCC) Signs New Patent License Agreement with Sony
InterDigital, Inc. (NASDAQ:IDCC) is one of the Unstoppable AI Stocks to Invest In Now.
Needham Raises PT on Allegro MicroSystems, Inc. (ALGM) Stock
Allegro MicroSystems, Inc. (NASDAQ:ALGM) is one of the Unstoppable AI Stocks to Invest In Now.
Ondas Inc. (ONDS): Airobotics Bags New Multi-million-dollar Order for Iron Drone Raider™ Counter-UAS System
Ondas Inc. (NASDAQ:ONDS) is one of the Unstoppable AI Stocks to Invest In Now.
Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX)
On February 9, David Westenberg from Piper Sandler maintained his Overweight rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX).
O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD)
On February 4, Stifel lowered its price target on Insulet Corporation (NASDAQ:PODD) from $370 to $350.
Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive
On February 11, Richard Newitter from Truist Financial reduced the price target on Edwards Lifesciences Corporation (NYSE:EW) from $92 to $89.
GE HealthCare Technologies Inc. (GEHC) Positioned to Capitalize on Strong Demand Backlog
The analyst noted the company’s fourth-quarter results, which beat expectations and improved the stock’s risk-reward profile.
Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery
On February 2, the price target on Abbott Laboratories (NYSE:ABT) was reduced from $169 to $142 by Barclays analyst Matt Miksic.
DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership
On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom, Inc. (NASDAQ:DXCM) from $99 to $95.
Stryker Corporation (SYK) Gains Strength From Procedure Volumes and Capital Equipment Backlog
On February 2, the price target on Stryker Corporation (NYSE:SYK) was raised from $462 to $469 by Barclays.
Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)
On January 27, Freedom Capital increased the price target on Intuitive Surgical, Inc.
Here is Why Boston Scientific Corporation (BSX) is Highly Favored by Hedge Funds
On February 17, the price target on Boston Scientific Corporation (NYSE:BSX) was reduced from $112 to $109 by Canaccord Genuity analyst William Plovanic.
Medtronic plc (MDT) Gains Momentum Through Diabetes and Cardiovascular Operations
On February 19, Truist analyst Richard Newitter reduced the price target on Medtronic plc (NYSE:MDT) from $107 to $103, while maintaining a Hold rating.
10 Best Aerospace and Defense Stocks to Invest In Right Now
On January 24, Tony Bancroft, Portfolio Manager at Gabelli Funds, appeared in an interview with Yahoo Finance to discuss the outlook for aerospace and defense stocks in 2026...
Lam Research (LRCX) Expands Footprint Amid Industry Momentum
Lam Research Corporation (NASDAQ:LRCX) is one of Goldman Sachs’s top growth stock picks.
Eli Lilly (LLY) Expands Pipeline With Positive Trial Data and New Licensing Deal
Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’s top growth stock picks.
Meta (META) Strengthens Investor Appeal With Dividend Payout and Platform Expansion Efforts
Meta Platforms, Inc. (NASDAQ:META) is one of Goldman Sachs’s top growth stock picks. On February 12, the board of directors of Meta Platforms, Inc.
Broadcom (AVGO) Draws Investor Interest Amid AI Growth Expectations
Broadcom Inc. (NASDAQ:AVGO) is one of Goldman Sachs’s top growth stock picks.
Amazon (AMZN) Navigates Investment Cycle and Strategic Developments
Amazon.com, Inc. (NASDAQ:AMZN) is one of Goldman Sachs’s top growth stock picks. On February 20, Moody’s Ratings revised its outlook on Amazon.com, Inc.
Microsoft (MSFT) Positions for Long-Term AI and Enterprise Growth
Microsoft Corporation (NASDAQ:MSFT) is one of Goldman Sachs’s top growth stock picks.
Is Shopify Inc. (SHOP) is One of Goldman Sachs’s Top Growth Stock Picks?
Shopify Inc. (NYSE:SHOP) is one of Goldman Sachs’s top growth stock picks. On February 17, Truist Securities analyst Terry Tillman upgraded Shopify, Inc.
Nvidia (NVDA) Draws Attention Amid Ownership Trends and Strategic Moves
NVIDIA Corporation (NASDAQ:NVDA) is one of Goldman Sachs’s top growth stock picks.
Alphabet (GOOGL) Expands AI Reach Amid Market Debate
Alphabet Inc. (NASDAQ:GOOGL) is one of Goldman Sachs’s top growth stock picks. On February 18, Google, an Alphabet Inc.
Hedge Fund Resource Center
